PTCT PTC Therapeutics, Inc. - Common Stock
$73.37
株価 · 8月 18, 2026
ファンダメンタルズ（時点） 7月 30, 2026
52週レンジ
$48–$91
59% of range
アナリスト評価
BUY
21 analysts
目標株価
$98
+33% upside
P/E (TTM)
9.4
ROE
-331.5%
純利益率
39.4%
PTC Therapeutics, Inc. - Common Stock について Wikipediaからの企業概要
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
続きを読む
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
In September 2009, PTC entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases. PTC acquired the Bio-e platform in 2019.
Products
In 2017, PTC acquired Emflaza (deflazacort) from Marathon Pharmaceuticals. PTC also owns Translarna, (Ataluren) marketed for nonsense mutation Duchenne muscular dystrophy. Together, the two products generated revenues of 174 million dollars and 260 million dollars in 2017 and 2018 respectively.
PTC has the commercialization rights for WAYLIVRA (volanesorsen) in Latin America.
In 2018, PTC acquired Agilis Biotherapeutics and a gene therapy candidate, GT-AADC, with its compelling clinical data in treating aromatic L-amino acid decarboxylase (AADC) deficiency. AADC deficiency is a rare CNS disorder arising from reductions in the enzyme AADC that result from mutations in the dopa decarboxylase (DDC) gene. As of 2024, the AAV based treatment for AADC deficiency has been approved by the FDA and commercialized in the United States as Kebilidi. It is the first FDA-approved gene therapy treatment for AADC deficiency. This same product was granted EMA approval for use in the European Union under the name Upstaza.
Pipeline
In 2020, PTC acquired Censa Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of CNSA-001 (sepiapterin), a clinical-stage investigational therapy for orphan metabolic diseases, including phenylketonuria (PKU) and other diseases associated with defects in the tetrahydrobiopterin (BH4) biochemical pathways diagnosed at birth.
In 2020, PTC announced the FDA approval of Evrysdi (risdiplam) for the treatment of spinal muscular atrophy (SMA) in adults and children 2 months and older.
In 2024, Novartis has committed $1 billion upfront in a licensing deal with PTC Therapeutics for an experimental treatment for Huntington’s disease, with the potential for an additional $1.9 billion tied to achieving specific development, regulatory, and commercial milestones. PTC Therapeutics’ therapy, known as PTC518, is an oral medication designed to reduce the production of the mutant protein linked to the genetic mutation responsible for the disease. This mutant protein is believed to contribute to neuronal death, driving disease progression. In June, interim data from a Phase 2 trial indicated that PTC518 successfully lowered levels of the mutant protein in both blood and cerebrospinal fluid.
出典: Wikipedia (英語), CC BY-SA 4.0 · Wikipediaで表示 ↗
PTCT 株価スナップショット 価格、時価総額、P/E、EPS、ROE、負債/資本、52週レンジ
株価
$73.36
時価総額
$5.98B
P/E (TTM)
9.4
EPS（TTM）
$7.78
収益（TTM）
$1.73B
配当利回り
—
ROE
-331.5%
負債/自己資本
-1.4
52週レンジ
$48 – $91
PTCT 株価チャート 技術指標付きの日次 OHLCV — パン、ズーム、ビューのカスタマイズ
Configure
10年間のパフォーマンス 収益、純利益、利益率、EPSのトレンド
収益と純利益
$1.73B
2016-12-31
→
2025-12-31
EPS
$7.78
2019-12-31
→
2025-12-31
フリーキャッシュフロー
$702M
2016-12-31
→
2025-12-31
利益率
39.4%
バリュエーション P/E、P/S、P/B、EV/EBITDA比率 — 株は割高か割安か？
指標
5年トレンド
PTCT
競合中央値
P/E (TTM)
9.4
37.2
P/S (TTM) (株価売上高倍率（TTM）)
3.5
9.9
P/B (株価純資産倍率)
-29.1
8.3
EV / EBITDA (EV/EBITDA)
4.8
—
Price / FCF (株価FCF倍率)
8.5
—
収益性 粗利益率、営業利益率、純利益率、ROE、ROA、ROIC
指標
5年トレンド
PTCT
競合中央値
Operating Margin (営業利益率)
50.1%
—
Net Profit Margin (純利益率)
39.4%
-15.1%
ROA
29.7%
-23.3%
ROE
-331.5%
-30.6%
ROIC
1044.7%
—
財務健全性 負債、流動性、支払能力 — バランスシートの健全性
指標
5年トレンド
PTCT
競合中央値
Debt / Equity (負債資本倍率)
-1.4
—
Current Ratio (流動比率)
2.3
6.3
Quick Ratio (クイックレシオ)
2.2
—
成長 収益、EPS、純利益の成長率：前年比、3年CAGR、5年CAGR
指標
5年トレンド
PTCT
競合中央値
Revenue YoY (収益（前年比）)
114.5%
—
Revenue CAGR 3Y (収益（3年CAGR）)
35.3%
—
Revenue CAGR 5Y (収益（5年CAGR）)
35.4%
—
資本効率 総資産回転率、棚卸資産回転率、売掛金回転率
指標
5年トレンド
PTCT
競合中央値
PTCT アナリストコンセンサス 強気・弱気のアナリストの見解、12ヶ月の目標株価、アップサイド
買い
21 アナリスト
- 強い買い 6 28.6%
- 買い 11 52.4%
- 保有 3 14.3%
- 売り 1 4.8%
- 強い売り 0 0.0%
12ヶ月目標株価
14 アナリスト · 2026-08-13
中央値
$98.00
現在
$73.36
安値
$70.00
高値
$130.00
中央値ターゲット
$98.00
+33.6%
平均値ターゲット
$97.86
+33.4%
決算履歴 EPS実績 vs 予想、サプライズ%、達成率、次回決算日
平均サプライズ
1.9%
| 期間 | EPS Actual | EPS 予想 | サプライズ |
|---|---|---|---|
| 2026年6月30日 | $0.92 | $0.43 | 0.49% |
| 2026年3月31日 | $-0.03 | $-0.48 | 0.45% |
| 2025年12月31日 | $-1.67 | $0.04 | -1.7% |
| 2025年9月30日 | $0.20 | $-1.40 | 1.6% |
| 2025年6月30日 | $-0.83 | $-1.08 | 0.25% |
| 2025年3月31日 | $10.04 | $-0.22 | 10.3% |
同業他社比較（GICSサブインダストリー） 主要メトリクスとセクターピアの比較
| ティッカー | 時価総額 | P/E | 売上高 YoY | 純利益率 | ROE | 粗利益率 |
|---|---|---|---|---|---|---|
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | — |
| MIRM | $4.10B | -168.1 | 54.7% | -4.5% | -8.2% | — |
| ERAS | $1.06B | -8.5 | — | — | -35.7% | — |
| SRRK | $4.78B | -13.4 | — | — | -157.9% | — |
| DNTH | $1.78B | -9.8 | -67.3% | -7973.3% | -40.8% | — |
| CAI | $7.62B | -8.4 | 97.0% | -8.4% | -13.2% | — |
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | — |
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | — |
| DYN | $3.23B | -5.6 | — | — | -57.8% | — |
完全なファンダメンタルズ 年次別全指標 — 損益計算書、貸借対照表、キャッシュフロー
損益計算書 15
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.73B | $807M | $938M | $699M | $539M | $381M | $307M | $265M | $194M | $83M | $37M | $25M | |
| Cost of Revenue | · | · | · | · | · | · | $12M | $13M | $5M | $0 | $0 | · | |
| R&D Expense | $455M | $534M | $667M | $651M | $541M | $478M | $257M | $172M | $117M | $118M | $122M | $80M | |
| SG&A Expense | $347M | $301M | $333M | $326M | $286M | $245M | $203M | $154M | $121M | $97M | $82M | $45M | |
| Operating Expenses | $864M | $1.11B | $1.38B | $1.15B | $913M | $813M | $548M | $380M | $259M | $215M | $204M | $125M | |
| Operating Income | $867M | $-303M | $-440M | $-447M | $-374M | $-432M | $-241M | $-116M | $-64M | $-132M | $-167M | $-99M | |
| Other Non-op | $-18M | $7M | $10M | $-49M | $-58M | $85M | $14M | $129.0K | $-1M | $-1M | $-465.0K | $-213.0K | |
| Pretax Income | $697M | $-363M | $-696M | $-587M | $-518M | $-403M | $-240M | $-128M | $-78M | $-142M | $-170M | $-98M | |
| Income Tax | $14M | $176.0K | $-70M | $-28M | $6M | $35M | $12M | $-29.0K | $1M | $569.0K | $485.0K | $-5M | |
| Net Income | $683M | $-363M | $-627M | $-559M | $-524M | $-438M | $-252M | $-128M | $-79M | $-142M | $-170M | $-94M | |
| EPS (Basic) | $8.58 | $-4.73 | $-8.37 | $-7.79 | $-7.43 | $-6.64 | $-4.27 | $-2.75 | $-2.02 | · | · | $-2.97 | |
| EPS (Diluted) | $7.78 | $-4.73 | $-8.37 | $-7.79 | $-7.43 | $-6.64 | $-4.27 | · | · | · | · | $-2.97 | |
| Shares (Basic) | 79,534,290 | 76,845,055 | 74,838,292 | 71,728,634 | 70,466,393 | 66,027,908 | 58,863,185 | · | · | · | · | 31,565,310 | |
| Shares (Diluted) | 88,311,494 | 76,845,055 | 74,838,292 | 71,728,634 | 70,466,393 | 66,027,908 | 58,863,185 | · | · | · | · | 31,565,310 | |
| EBITDA | $906M | $-227M | $-203M | · | $-310M | $-388M | $-209M | $-90M | $-47M | $-132M | $-167M | $-99M |
貸借対照表 27
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $985M | $780M | $594M | $280M | $190M | $209M | $288M | $169M | $112M | $58M | $58M | $50M | |
| Short-term Investments | $961M | $360M | $283M | $131M | $584M | $895M | $399M | $58M | $79M | $173M | $281M | $265M | |
| Receivables | $182M | $159M | $161M | $156M | $110M | $70M | $56M | $68M | $40M | $25M | $11M | $4M | |
| Inventory | $80M | $23M | $31M | $22M | $16M | $19M | $19M | $16M | $11M | $0 | · | · | |
| Prepaid Expense | $67M | $44M | $150M | $106M | $55M | $39M | $18M | $9M | $7M | $5M | $6M | $4M | |
| Current Assets | $2.27B | $1.37B | $1.22B | $694M | $954M | $1.23B | $779M | $321M | $249M | $261M | $356M | $324M | |
| PP&E (Net) | $55M | $61M | $87M | $73M | $53M | $34M | $22M | $13M | $8M | $7M | $9M | $9M | |
| PP&E (Gross) | $102M | $94M | $138M | $110M | $80M | $52M | $33M | $20M | $41M | $38M | $37M | $34M | |
| Accum. Depreciation | $47M | $33M | $51M | $37M | $27M | $18M | $12M | $7M | $33M | $31M | $28M | $25M | |
| Goodwill | $82M | $82M | $82M | $82M | $82M | $82M | $82M | $82M | $0 | · | · | · | |
| Intangibles | $389M | $119M | $379M | $706M | $725M | $715M | $710M | $701M | $133M | $0 | · | · | |
| Total Assets | $2.90B | $1.71B | $1.90B | $1.71B | $1.94B | $2.21B | $1.62B | $1.12B | $392M | $269M | $365M | $333M | |
| Accounts Payable | $45M | $17M | $6M | $27M | $23M | $19M | $10M | $6M | $15M | $6M | $6M | $4M | |
| Current Liabilities | $968M | $581M | $603M | $406M | $509M | $277M | $236M | $167M | $82M | $50M | $45M | $32M | |
| Capital Leases | $94M | $75M | $98M | $101M | $74M | $79M | $9M | · | · | · | · | · | |
| Deferred Tax | · | · | $56M | $103M | $137M | $137M | $131M | $122M | $0 | · | · | · | |
| Other Non-current Liabilities | $14M | $21M | $141.0K | $3M | · | $1M | $141.0K | $58.0K | $243.0K | $335.0K | $2M | $2M | |
| Total Liabilities | $3.10B | $2.80B | $2.71B | $2.05B | $1.94B | $1.73B | $1.03B | $768M | $235M | $150M | $139M | $35M | |
| Long-term Debt | · | · | · | · | $431M | · | $314M | $153M | $145M | · | · | · | |
| Total Debt | $287M | $285M | $284M | · | $431M | $309M | $314M | $153M | $145M | $98M | $95M | · | |
| Common Stock | $80.0K | $77.0K | $75.0K | $72.0K | $71.0K | $70.0K | $62.0K | $51.0K | $42.0K | $34.0K | $34.0K | $33.0K | |
| Paid-in Capital | $2.75B | $2.57B | $2.47B | $2.31B | $2.12B | $2.17B | $1.80B | $1.29B | $967M | $856M | $820M | $722M | |
| Retained Earnings | $-2.96B | $-3.65B | $-3.28B | $-2.66B | $-2.10B | $-1.63B | $-1.19B | $-939M | $-814M | $-735M | $-593M | $-423M | |
| AOCI | $11M | $-26M | $-1M | $5M | $-24M | $-61M | $-11M | $1M | $4M | $-1M | $-1M | $-737.0K | |
| Stockholders' Equity | $-205M | $-1.10B | $-819M | $-347M | $1M | $482M | $594M | $351M | $156M | $120M | $226M | $298M | |
| Liabilities + Equity | $2.90B | $1.71B | $1.90B | $1.71B | $1.94B | $2.21B | $1.62B | $1.12B | $392M | $269M | $365M | $333M | |
| Shares Outstanding | 81,474,366 | 77,704,188 | 75,708,889 | 73,104,692 | 70,828,226 | 69,718,096 | 61,935,870 | 50,606,147 | 41,612,395 | 34,169,410 | 33,916,559 | 32,898,392 |
キャッシュフロー 16
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $39M | $76M | $237M | $129M | $64M | $43M | $32M | $26M | $18M | $3M | $3M | · | |
| Stock-based Comp | $75M | $75M | $102M | $110M | $104M | $70M | $42M | $33M | $31M | $35M | $34M | $19M | |
| Deferred Tax | $-3.0K | $-56M | $-47M | $-34M | $377.0K | $6M | $9M | $0 | $199.0K | $-199.0K | $0 | $0 | |
| Amort. of Intangibles | $25M | $61M | $223M | $117M | $55M | $37M | $28M | $23M | $15M | $0 | $0 | · | |
| Restructuring | · | · | · | · | · | · | · | · | $0 | · | · | · | |
| Other Non-cash | $-85M | $161M | $177M | · | $105M | $124M | $70M | $41M | $20M | · | · | · | |
| Operating Cash Flow | $711M | $-108M | $-158M | $-357M | $-251M | $-194M | $-99M | $-28M | $-10M | $-104M | $-124M | $-57M | |
| CapEx | $9M | $7M | $28M | $32M | $28M | $18M | $14M | $7M | $3M | $2M | $3M | $5M | |
| Investing Cash Flow | $-862M | $44M | $-177M | $290M | $219M | $-562M | $-387M | $-43M | $13M | $104M | $-21M | $-145M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | · | $-49.0K | |
| Stock Issued | · | · | · | · | · | $28M | $324M | $118M | $0 | $0 | $0 | $236M | |
| Net Stock Activity | · | · | · | · | · | $28M | $324M | $118M | · | $0 | · | $236M | |
| Financing Cash Flow | $331M | $256M | $646M | $168M | $21M | $669M | $613M | $132M | $44M | $968.0K | $154M | $237M | |
| Net Change in Cash | $203M | $185M | $314M | $99M | $-19M | $-79M | $126M | $58M | $53M | $299.0K | $8M | $34M | |
| Taxes Paid | $37M | $18M | $14M | $5M | $8M | $26M | $2M | $2M | $1M | $943.0K | $111.0K | $0 | |
| Free Cash Flow | $702M | $-114M | $-187M | · | $-280M | $-212M | $-112M | $-35M | $-13M | $-105M | $-127M | $-62M |
収益性 7
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 50.1% | -37.5% | -46.9% | · | -69.5% | -113.4% | -78.6% | -43.7% | -33.1% | -159.7% | -454.6% | -393.8% | |
| Net Margin | 39.4% | -45.0% | -66.8% | · | -97.3% | -115.1% | -82.0% | -48.4% | -40.6% | -171.8% | -463.6% | -371.4% | |
| Pretax Margin | 40.2% | -45.0% | -74.2% | · | -96.2% | -105.8% | -78.2% | -48.4% | -40.0% | -171.1% | -462.3% | -390.0% | |
| EBITDA Margin | 52.3% | -28.1% | -21.6% | · | -57.6% | -102.0% | -68.1% | -33.8% | -24.0% | -159.7% | -454.6% | -393.8% | |
| ROA | 29.7% | -20.2% | -34.8% | · | -25.3% | -22.9% | -18.3% | -17.0% | -23.9% | -44.8% | -48.6% | -38.6% | |
| ROE | -331.5% | 33.8% | 84.1% | · | -985.1% | -88.3% | -40.0% | -34.8% | -57.2% | -82.2% | -65.0% | -43.1% | |
| ROIC | 1044.7% | 37.2% | 74.0% | · | -87.4% | -59.4% | -27.8% | -23.0% | -21.7% | -60.9% | -52.3% | -31.7% |
流動性と支払能力 4
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.3 | 2.4 | 2.0 | · | 1.9 | 4.4 | 3.3 | 1.9 | 3.0 | 5.3 | 7.8 | 10.0 | |
| Quick Ratio | 2.2 | 2.2 | 1.7 | · | 1.7 | 4.2 | 3.1 | 1.8 | 2.8 | 5.2 | 7.7 | 9.8 | |
| Debt / Equity | -1.4 | -0.3 | -0.3 | · | 300.0 | 0.6 | 0.5 | 0.4 | 0.9 | 0.8 | 0.4 | · | |
| LT Debt / Equity | · | -0.3 | -0.3 | · | 196.0 | 0.6 | 0.5 | 0.4 | 0.9 | 0.8 | 0.4 | · |
効率性 3
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.4 | 0.5 | · | 0.3 | 0.2 | 0.2 | 0.4 | 0.6 | 0.3 | 0.1 | 0.1 | |
| Inventory Turnover | · | · | · | · | · | · | 0.7 | · | 0.9 | · | · | · | |
| Receivables Turnover | 10.2 | 5.1 | 5.9 | · | 6.0 | 6.1 | 5.0 | 4.9 | 6.0 | 4.6 | 4.7 | 9.3 |
成長率 3
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 114.5% | -14.0% | 34.2% | 29.8% | 41.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 35.3% | 14.4% | 35.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 35.4% | · | · | · | · | · | · | · | · | · | · | · |
バリュエーション（TTM） 13
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.73B | $807M | $938M | $699M | $539M | $381M | $307M | $265M | $194M | $83M | $37M | $25M | |
| Net Income TTM | $683M | $-363M | $-627M | $-559M | $-524M | $-438M | $-252M | $-128M | $-79M | $-142M | $-170M | $-94M | |
| Market Cap | $6.19B | $3.51B | $2.09B | · | $2.82B | $4.25B | $2.97B | $1.74B | $694M | $373M | $1.10B | $1.70B | |
| Enterprise Value | $4.53B | $2.65B | $1.49B | · | $2.48B | $3.46B | $2.60B | $1.66B | $648M | $239M | $855M | · | |
| P/E | 9.8 | -9.5 | -3.3 | -4.9 | -5.4 | -9.2 | -11.2 | -10.7 | -5.2 | -3.4 | -10.1 | -17.4 | |
| P/S | 3.6 | 4.3 | 2.2 | · | 5.2 | 11.2 | 9.7 | 6.6 | 3.6 | 4.5 | 29.9 | 67.5 | |
| P/B | -30.1 | -3.2 | -2.5 | · | 1961.8 | 8.8 | 5.0 | 5.0 | 4.4 | 3.1 | 4.9 | 5.7 | |
| P / Cash Flow | 8.7 | -32.6 | -13.2 | · | -11.2 | -21.9 | -30.2 | -62.8 | -69.0 | -3.6 | -8.8 | -29.7 | |
| P / FCF | 8.8 | -30.7 | -11.2 | · | -10.1 | -20.1 | -26.5 | -50.0 | -52.7 | -3.5 | -8.6 | -27.5 | |
| EV / EBITDA | 5.0 | -11.7 | -7.4 | · | -8.0 | -8.9 | -12.5 | -18.6 | -13.9 | -1.8 | -5.1 | · | |
| EV / FCF | 6.5 | -23.2 | -8.0 | · | -8.9 | -16.3 | -23.2 | -47.9 | -49.2 | -2.3 | -6.7 | · | |
| EV / Revenue | 2.6 | 3.3 | 1.6 | · | 4.6 | 9.1 | 8.5 | 6.3 | 3.3 | 2.9 | 23.2 | · | |
| Earnings Yield | 10.2% | -10.5% | -30.4% | -20.4% | -18.6% | -10.9% | -8.9% | -9.3% | -19.2% | -29.4% | -9.9% | -5.7% |
損益計算書 14
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $361M | $273M | $165M | $211M | $179M | $1.18B | $213M | $197M | $187M | $210M | $307M | $197M | $214M | $220M | $167M | $217M | |
| R&D Expense | $99M | $101M | $133M | $100M | $113M | $109M | $125M | $161M | $132M | $116M | $121M | $164M | $186M | $195M | $189M | $165M | |
| SG&A Expense | $81M | $86M | $97M | $84M | $85M | $81M | $85M | $73M | $70M | $73M | $76M | $81M | $88M | $87M | $93M | $80M | |
| Operating Expenses | $212M | $228M | $236M | $208M | $214M | $206M | $376M | $251M | $227M | $256M | $301M | $315M | $423M | $338M | $368M | $285M | |
| Operating Income | $149M | $45M | $-71M | $3M | $-35M | $970M | $-162M | $-55M | $-40M | $-45M | $6M | $-118M | $-210M | $-118M | $-200M | $-68M | |
| Other Non-op | $-3M | $2M | $-13M | $7M | $-6M | $-6M | $9M | $-2M | $-2M | $2M | $19M | $-20M | $1M | $10M | $35M | $-38M | |
| Pretax Income | $98M | $-2M | $-139M | $-23M | $-71M | $930M | $-95M | $-98M | $-86M | $-85M | $-157M | $-167M | $-237M | $-135M | $-190M | $-127M | |
| Income Tax | $14M | $347.0K | $-4M | $-39M | $-6M | $63M | $-29M | $9M | $13M | $7M | $-1M | $-34M | $-39M | $4M | $-19M | $-18M | |
| Net Income | $83M | $-3M | $-135M | $16M | $-65M | $867M | $-66M | $-107M | $-99M | $-92M | $-156M | $-133M | $-199M | $-139M | $-171M | $-109M | |
| EPS (Basic) | $1.01 | $-0.03 | $-1.88 | $0.20 | $-0.83 | $11.09 | $-0.85 | $-1.39 | $-1.29 | $-1.20 | $-2.07 | $-1.76 | $-2.66 | $-1.88 | $-2.35 | $-1.53 | |
| EPS (Diluted) | $0.92 | $-0.03 | $-1.63 | $0.20 | $-0.83 | $10.04 | $-0.85 | $-1.39 | $-1.29 | $-1.20 | $-2.07 | $-1.76 | $-2.66 | $-1.88 | $-2.35 | $-1.53 | |
| Shares (Basic) | 83,006,808 | 82,521,023 | -155,203,905 | 78,471,119 | 78,151,240 | 78,115,836 | -153,301,665 | 76,925,523 | 76,725,070 | 76,496,127 | -148,999,422 | 75,377,997 | 74,730,433 | 73,729,284 | -142,514,082 | 71,654,671 | |
| Shares (Diluted) | 92,020,009 | 82,521,023 | -163,341,037 | 87,115,369 | 78,151,240 | 86,385,922 | -153,301,665 | 76,925,523 | 76,725,070 | 76,496,127 | -148,999,422 | 75,377,997 | 74,730,433 | 73,729,284 | -142,514,082 | 71,654,671 | |
| EBITDA | $149M | $60M | · | $3M | $-35M | $977M | · | $-55M | $-40M | $10M | · | $-118M | $-210M | $-75M | · | $-68M |
貸借対照表 27
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.05B | $834M | $985M | $673M | $1.02B | $1.48B | $780M | $526M | $655M | $548M | · | $165M | $208M | $167M | · | $104M | |
| Short-term Investments | $1.18B | $1.06B | $961M | $1.02B | $972M | $547M | $360M | $487M | $439M | $336M | · | $130M | $130M | $119M | · | $184M | |
| Receivables | $239M | $220M | $182M | $203M | $196M | $210M | $159M | $200M | $187M | $198M | · | $166M | $178M | $202M | · | $124M | |
| Inventory | $91M | $76M | $80M | $53M | $34M | $22M | $23M | $36M | $32M | $30M | · | $36M | $32M | $27M | · | $15M | |
| Prepaid Expense | $58M | $66M | $67M | $64M | $54M | $57M | $44M | $33M | $46M | $56M | · | $44M | $42M | $99M | · | $90M | |
| Current Assets | $2.62B | $2.25B | $2.27B | $2.01B | $2.27B | $2.32B | $1.37B | $1.28B | $1.36B | $1.17B | · | $540M | $590M | $613M | · | $517M | |
| PP&E (Net) | $51M | $53M | $55M | $57M | $57M | $59M | $61M | $63M | $66M | $93M | · | $85M | $82M | $79M | · | $67M | |
| PP&E (Gross) | · | · | $102M | · | · | · | $94M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $47M | · | · | · | $33M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $82M | $82M | $82M | $82M | $82M | $82M | $82M | $82M | $82M | $82M | · | $82M | $82M | $82M | · | $82M | |
| Intangibles | $403M | $381M | $389M | $396M | $144M | $118M | $119M | $330M | $330M | $330M | · | $423M | $452M | $686M | · | $750M | |
| Total Assets | $3.25B | $2.87B | $2.90B | $2.64B | $2.63B | $2.66B | $1.71B | $1.84B | $1.92B | $1.79B | · | $1.26B | $1.34B | $1.61B | · | $1.58B | |
| Accounts Payable | $40M | $25M | $45M | $37M | $27M | $15M | $17M | $13M | $24M | $27M | · | $19M | $26M | $26M | · | $21M | |
| Current Liabilities | $771M | $924M | $968M | $866M | $628M | $595M | $581M | $611M | $610M | $575M | · | $492M | $476M | $442M | · | $420M | |
| Capital Leases | $88M | $90M | $94M | $95M | $71M | $74M | $75M | $83M | $79M | $105M | · | $100M | $100M | $100M | · | $102M | |
| Deferred Tax | · | · | · | · | · | · | · | $56M | $56M | $56M | · | $52M | $52M | $103M | · | $137M | |
| Other Non-current Liabilities | $15M | $14M | $14M | $3M | $8M | $22M | $21M | $77.0K | $141.0K | $141.0K | · | $141.0K | $141.0K | $141.0K | · | $5M | |
| Total Liabilities | $3.42B | $3.05B | $3.10B | $2.80B | $2.84B | $2.84B | $2.80B | $2.90B | $2.90B | $2.68B | · | $1.93B | $1.92B | $2.07B | · | $1.80B | |
| Long-term Debt | $591M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $591M | $287M | · | $286M | $286M | $286M | · | $285M | $285M | $285M | · | $573M | $573M | $572M | · | $283M | |
| Common Stock | $82.0K | $81.0K | $80.0K | $79.0K | $78.0K | $78.0K | $77.0K | $76.0K | $76.0K | $76.0K | · | $75.0K | $75.0K | $73.0K | · | $71.0K | |
| Paid-in Capital | $2.71B | $2.78B | $2.75B | $2.67B | $2.63B | $2.61B | $2.57B | $2.53B | $2.51B | $2.49B | · | $2.45B | $2.42B | $2.34B | · | $2.22B | |
| Retained Earnings | $-2.88B | $-2.97B | $-2.96B | $-2.83B | $-2.85B | $-2.78B | $-3.65B | $-3.58B | $-3.47B | $-3.38B | · | $-3.13B | $-2.99B | $-2.80B | · | $-2.49B | |
| AOCI | $6M | $8M | $11M | $6M | $7M | $-14M | $-26M | $-4M | $-16M | $-6M | · | $10M | $-1M | $-2M | · | $36M | |
| Stockholders' Equity | $-165M | $-180M | $-205M | $-156M | $-207M | $-186M | $-1.10B | $-1.05B | $-980M | $-894M | $-819M | $-671M | $-579M | $-458M | $-347M | $-227M | |
| Liabilities + Equity | $3.25B | $2.87B | $2.90B | $2.64B | $2.63B | $2.66B | $1.71B | $1.84B | $1.92B | $1.79B | · | $1.26B | $1.34B | $1.61B | · | $1.58B | |
| Shares Outstanding | 83,327,286 | 82,882,024 | 81,474,366 | 79,931,766 | 79,378,145 | 79,225,276 | 77,704,188 | 76,952,124 | 76,900,123 | 76,653,960 | · | 75,459,022 | 75,318,233 | 74,012,034 | · | 71,854,892 |
キャッシュフロー 13
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $16M | $15M | $13M | $11M | $8M | $7M | $7M | $6M | $7M | $55M | $81M | $62M | $51M | $43M | $39M | $34M | |
| Stock-based Comp | $23M | $23M | $19M | $19M | $19M | $18M | $17M | $20M | $19M | $18M | $17M | $27M | $29M | $29M | $27M | $29M | |
| Deferred Tax | · | $-10.0K | $1.0K | · | · | $2.0K | $-56M | $-3.0K | $2.0K | $-1.0K | $4M | $-2.0K | $-51M | $-4.0K | · | · | |
| Amort. of Intangibles | $12M | $12M | $9M | $8M | $4M | $4M | $3M | $3M | $3M | $52M | $77M | $59M | $47M | $39M | $36M | $31M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | $23M | $8M | · | · | · | |
| Other Non-cash | · | $-95M | · | · | · | $-22M | · | · | · | $89M | · | · | · | $38M | · | · | |
| Operating Cash Flow | $129M | $-59M | $-34M | $-66M | $-58M | $870M | $-30M | $-77M | $-71M | $71M | $-100M | $-15M | $-14M | $-29M | $-166M | $-38M | |
| CapEx | $2M | $1M | $2M | $3M | $1M | $2M | $4M | $522.0K | $-7M | $10M | $6M | $6M | $6M | $10M | $9M | $5M | |
| Investing Cash Flow | $-123M | $-94M | $34M | $-290M | $-422M | $-184M | $268M | $-43M | $-66M | $-115M | $-94M | $-30M | $-24M | $-29M | $32M | $136M | |
| Financing Cash Flow | $212M | $6M | $303M | $15M | $4M | $9M | $26M | $-18M | $246M | $540.0K | $620M | $3M | $18M | $4M | $303M | $-140M | |
| Net Change in Cash | $216M | $-148M | $312M | $-347M | $-463M | $701M | $256M | $-129M | $104M | $-46M | $429M | $-43M | $-9M | $-62M | $175M | $-54M | |
| Taxes Paid | · | · | $-3M | $936.0K | $36M | $3M | $5M | $7M | $4M | $2M | $524.0K | $4M | $7M | $2M | $893.0K | $1M | |
| Free Cash Flow | · | $-60M | · | · | · | $868M | · | · | · | $61M | · | · | · | $-40M | · | · |
収益性 7
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 41.3% | 16.5% | · | 1.4% | -19.5% | 82.5% | · | -27.7% | -21.5% | -21.6% | · | -60.1% | -98.0% | -53.4% | · | -31.4% | |
| Net Margin | 23.2% | -1.0% | · | 7.5% | -36.2% | 73.7% | · | -54.2% | -53.1% | -43.6% | · | -67.6% | -93.0% | -63.0% | · | -50.3% | |
| Pretax Margin | 27.1% | -0.90% | · | -10.9% | -39.7% | 79.1% | · | -49.8% | -45.9% | -40.3% | · | -84.8% | -111.1% | -61.3% | · | -58.6% | |
| EBITDA Margin | 41.3% | 22.1% | · | 1.4% | -19.5% | 83.1% | · | -27.7% | -21.5% | 4.7% | · | -60.1% | -98.0% | -33.9% | · | -31.4% | |
| ROA | 2.8% | -0.10% | · | 0.71% | -2.9% | 39.0% | · | -6.9% | -6.1% | -5.4% | · | -9.4% | -12.7% | -8.2% | · | -6.1% | |
| ROE | -44.9% | 1.5% | · | -2.6% | 10.9% | -160.5% | · | 12.4% | 12.7% | 13.6% | · | 29.6% | 52.2% | 50.7% | · | 179.2% | |
| ROIC | 30.0% | 48.2% | · | -1.6% | -40.2% | 904.6% | · | 7.7% | 6.7% | 8.1% | · | 96.6% | 2648.9% | -105.7% | · | -104.9% |
流動性と支払能力 4
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 2.4 | · | 2.3 | 3.6 | 3.9 | · | 2.1 | 2.2 | 2.0 | · | 1.1 | 1.2 | 1.4 | · | 1.2 | |
| Quick Ratio | 3.2 | 2.3 | · | 2.2 | 3.5 | 3.8 | · | 2.0 | 2.1 | 1.9 | · | 0.9 | 1.1 | 1.1 | · | 1.0 | |
| Debt / Equity | -3.6 | -1.6 | · | -1.8 | -1.4 | -1.5 | · | -0.3 | -0.3 | -0.3 | · | -0.9 | -1.0 | -1.3 | · | -1.2 | |
| LT Debt / Equity | -3.2 | · | · | · | -1.4 | -1.5 | · | -0.3 | -0.3 | -0.3 | · | -0.9 | -1.0 | -1.3 | · | -1.2 |
効率性 2
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.5 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.7 | 1.3 | · | 1.0 | 0.9 | 5.8 | · | 1.1 | 1.0 | 1.1 | · | 1.4 | 1.4 | 1.3 | · | 2.0 |
バリュエーション（TTM） 13
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.02B | $1.84B | · | $1.76B | $1.74B | $1.77B | · | $790M | $807M | $841M | · | $848M | $817M | $752M | · | $670M | |
| Net Income TTM | $32M | $815M | · | $711M | $596M | $569M | · | $-430M | $-523M | $-562M | · | $-580M | $-599M | $-527M | · | $-522M | |
| Market Cap | $6.80B | $5.65B | · | $4.91B | $3.88B | $4.04B | · | $2.85B | $2.35B | $2.23B | · | $1.69B | $3.06B | $3.59B | · | $3.61B | |
| Enterprise Value | $5.16B | $4.04B | · | $3.50B | $2.17B | $2.30B | · | $2.13B | $1.54B | $1.63B | · | $1.97B | $3.30B | $3.87B | · | $3.60B | |
| P/E | 313.7 | 7.3 | · | 7.7 | 7.5 | 8.3 | · | -6.6 | -4.4 | -3.9 | · | -2.9 | -5.0 | -6.6 | · | -6.8 | |
| P/S | 6.6 | 3.1 | · | 2.8 | 2.2 | 2.3 | · | 3.6 | 2.9 | 2.7 | · | 2.0 | 3.8 | 4.8 | · | 5.4 | |
| P/B | -41.1 | -31.3 | · | -31.5 | -18.8 | -21.7 | · | -2.7 | -2.4 | -2.5 | · | -2.5 | -5.3 | -7.8 | · | -15.9 | |
| P / Cash Flow | · | -95.6 | · | · | · | 4.6 | · | · | · | 31.5 | · | · | · | -121.6 | · | · | |
| P / FCF | · | -93.7 | · | · | · | 4.6 | · | · | · | 36.5 | · | · | · | -90.2 | · | · | |
| EV / EBITDA | 34.6 | 66.9 | · | 1161.8 | -62.2 | 2.3 | · | -39.0 | -38.4 | 163.9 | · | -16.7 | -15.7 | -51.8 | · | -52.8 | |
| EV / FCF | · | -67.1 | · | · | · | 2.6 | · | · | · | 26.6 | · | · | · | -97.4 | · | · | |
| EV / Revenue | 5.0 | 2.2 | · | 2.0 | 1.3 | 1.3 | · | 2.7 | 1.9 | 1.9 | · | 2.3 | 4.0 | 5.1 | · | 5.4 | |
| Earnings Yield | 0.32% | 13.8% | · | 13.1% | 13.4% | 12.1% | · | -15.2% | -22.6% | -25.8% | · | -34.9% | -20.2% | -15.1% | · | -14.6% |
財務諸表 損益計算書、貸借対照表、キャッシュフロー — 年次、過去5年間
損益計算書
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 収益 | $1.73B | $807M | $938M | $699M | $539M |
| 営業利益率 % | 50.1% | -37.5% | -46.9% | — | -69.5% |
| 純利益 | $683M | $-363M | $-627M | $-559M | $-524M |
| 希薄化後EPS | $7.78 | $-4.73 | $-8.37 | $-7.79 | $-7.43 |
貸借対照表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 負債資本倍率 | -1.4 | -0.3 | -0.3 | — | 300.0 |
| 流動比率 | 2.3 | 2.4 | 2.0 | — | 1.9 |
| クイックレシオ | 2.2 | 2.2 | 1.7 | — | 1.7 |
キャッシュフロー
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| フリーキャッシュフロー | $702M | $-114M | $-187M | — | $-280M |
トレードシグナル エントリー価格とリスク/リワード比率を伴う最近の売買シグナル
マイ指標 あなた専用のウォッチリスト — 決算詳細から選択した行
📊
あなたにとって重要なメトリクスを選択 — 上記の決算詳細の任意の行の横にある➕をクリックしてください。
選択内容は保存され、すべてのティッカーで引き継がれます。
機関投資家（13F） 403 提出者 · $5.4B合計 · 時点 2026年6月30日
四半期SECフォーム13Fでこの株式の保有を報告している機関。ロングポジションのみ。単一の提出者は、別々のオプションレッグで2回表示される場合があります。 大きな反対売買のプット/コール・レッグは、通常、マーケットメイクまたはヘッジされた在庫を反映しており、方向性への確信を示すものではありません。
機関投資家の動向 — Q2 2026 対 前四半期
| 新規ポジション | 解消済みポジション | 増加 | 減少 | 純株式数増減 |
|---|---|---|---|---|
| 83 (+22 前期比) | 43 (-9 前期比) | 133 (-4 前期比) | 109 (+6 前期比) | +2.1M |
Q1 2026と比較しました。 SECフォーム13Fの提出期限は四半期末から45日後ですが、遅延提出者向けの短いバッファーが含まれます。この期間内の四半期は、直近で完全に報告されたペアを優先するためスキップされます。
| 機関投資家 | 評価額 | 株式数 | % 追跡された13Fのうち | タイプ |
|---|---|---|---|---|
| RTW INVESTMENTS, LP | $631,875,072 | 7,746,415 | 11.70% | 株式数 |
| JANUS HENDERSON GROUP PLC | $479,178,655 | 7,034,622 | 8.87% | 株式数 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $401,986,014 | 4,928,111 | 7.45% | 株式数 |
| STATE STREET CORP | $375,136,515 | 4,598,952 | 6.95% | 株式数 |
| VANGUARD CAPITAL MANAGEMENT LLC | $305,000,589 | 3,739,127 | 5.65% | 株式数 |
| WELLINGTON MANAGEMENT GROUP LLP | $292,435,873 | 3,585,091 | 5.42% | 株式数 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $159,563,645 | 1,956,156 | 2.96% | 株式数 |
| GEODE CAPITAL MANAGEMENT, LLC | $155,132,041 | 1,901,417 | 2.87% | 株式数 |
| Hood River Capital Management LLC | $141,818,662 | 1,738,613 | 2.63% | 株式数 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $140,519,660 | 1,722,688 | 2.60% | 株式数 |
| TANG CAPITAL MANAGEMENT LLC | $122,355,000 | 1,500,000 | 2.27% | 株式数 |
| Driehaus Capital Management LLC | $117,469,528 | 1,440,107 | 2.18% | 株式数 |
| Jefferies Financial Group Inc. | $110,693,916 | 1,357,042 | 2.05% | 株式数 |
| FULLER & THALER ASSET MANAGEMENT, INC. | $94,361,749 | 1,156,819 | 1.75% | 株式数 |
| Pictet Asset Management Holding SA | $93,629,635 | 1,147,844 | 1.73% | 株式数 |
| ARMISTICE CAPITAL, LLC | $87,393,690 | 1,071,395 | 1.62% | 株式数 |
| Blue Sparrow, LLC /DE | $85,705,599 | 1,050,700 | 1.59% | 株式数 |
| D. E. Shaw & Co., Inc. | $77,478,857 | 949,845 | 1.44% | 株式数 |
| Palo Alto Investors LP | $74,950,268 | 918,846 | 1.39% | 株式数 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $64,449,436 | 790,112 | 1.19% | 株式数 |
| RENAISSANCE TECHNOLOGIES LLC | $59,015,895 | 723,500 | 1.09% | 株式数 |
| Boston Partners | $57,080,953 | 699,871 | 1.06% | 株式数 |
| FMR LLC | $56,956,987 | 698,259 | 1.05% | 株式数 |
| BANK OF AMERICA CORP /DE/ | $56,350,840 | 690,828 | 1.04% | 株式数 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $53,377,940 | 654,382 | 0.99% | 株式数 |
| DIMENSIONAL FUND ADVISORS LP | $51,486,821 | 631,199 | 0.95% | 株式数 |
| VANGUARD FIDUCIARY TRUST CO | $47,953,943 | 587,887 | 0.89% | 株式数 |
| Ensign Peak Advisors, Inc | $41,442,128 | 508,056 | 0.77% | 株式数 |
| AMERICAN CENTURY COMPANIES INC | $40,866,277 | 500,995 | 0.76% | 株式数 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $36,050,432 | 441,957 | 0.67% | 株式数 |
| Parkman Healthcare Partners LLC | $35,539,315 | 435,691 | 0.66% | 株式数 |
| LOOMIS SAYLES & CO L P | $35,387,921 | 433,835 | 0.66% | 株式数 |
| Defilade Capital Management, L.P. | $35,376,827 | 433,699 | 0.66% | 株式数 |
| GOLDMAN SACHS GROUP INC | $34,153,522 | 418,702 | 0.63% | 株式数 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $32,274,149 | 395,662 | 0.60% | 株式数 |
| BNP PARIBAS FINANCIAL MARKETS | $30,892,190 | 378,720 | 0.57% | 株式数 |
| Qube Research & Technologies Ltd | $25,398,777 | 311,374 | 0.47% | 株式数 |
| ARMISTICE CAPITAL, LLC | $24,471,000 | 300,000 | 0.45% | コールオプション |
| Public Sector Pension Investment Board | $23,249,326 | 285,023 | 0.43% | 株式数 |
| SEGALL BRYANT & HAMILL, LLC | $22,165,424 | 271,735 | 0.41% | 株式数 |
| CITADEL ADVISORS LLC | $20,338,011 | 249,332 | 0.38% | 株式数 |
| MORGAN STANLEY | $18,990,210 | 232,808 | 0.35% | 株式数 |
| Boxer Capital Management, LLC | $16,314,000 | 200,000 | 0.30% | 株式数 |
| RHUMBLINE ADVISERS | $15,718,994 | 192,706 | 0.29% | 株式数 |
| AMERIPRISE FINANCIAL INC | $13,904,178 | 170,457 | 0.26% | 株式数 |
| PRUDENTIAL FINANCIAL INC | $13,746,176 | 168,520 | 0.25% | 株式数 |
| BlackRock, Inc. | $13,589,562 | 166,600 | 0.25% | 株式数 |
| Rock Springs Capital Management LP | $13,238,648 | 162,298 | 0.25% | 株式数 |
| Hudson Bay Capital Management LP | $13,033,091 | 159,778 | 0.24% | 株式数 |
| Russell Investments Group, Ltd. | $12,687,724 | 155,544 | 0.23% | 株式数 |
| Schonfeld Strategic Advisors LLC | $12,025,457 | 147,425 | 0.22% | 株式数 |
| MARSHALL WACE, LLP | $11,724,301 | 143,733 | 0.22% | 株式数 |
| Swiss National Bank | $11,539,300 | 141,465 | 0.21% | 株式数 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $11,063,583 | 135,633 | 0.20% | 株式数 |
| Legal & General Group Plc | $10,362,979 | 127,044 | 0.19% | 株式数 |
| CITIGROUP INC | $9,272,143 | 113,671 | 0.17% | 株式数 |
| FIRST TRUST ADVISORS LP | $9,246,285 | 113,354 | 0.17% | 株式数 |
| Longaeva Partners L.P. | $9,119,771 | 111,803 | 0.17% | 株式数 |
| JUPITER ASSET MANAGEMENT LTD | $8,927,184 | 109,442 | 0.17% | 株式数 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $8,215,404 | 100,716 | 0.15% | 株式数 |
| SECTOR GAMMA AS | $8,157,000 | 100,000 | 0.15% | 株式数 |
| WCM INVESTMENT MANAGEMENT, LLC | $7,651,184 | 93,799 | 0.14% | 株式数 |
| PANAGORA ASSET MANAGEMENT INC | $7,256,141 | 88,956 | 0.13% | 株式数 |
| VOYA INVESTMENT MANAGEMENT LLC | $7,239,501 | 88,752 | 0.13% | 株式数 |
| ALLIANCEBERNSTEIN L.P. | $7,217,488 | 105,937 | 0.13% | 株式数 |
| Aquatic Capital Management LLC | $6,808,648 | 83,470 | 0.13% | 株式数 |
| XTX Topco Ltd | $6,682,459 | 81,923 | 0.12% | 株式数 |
| MOORE CAPITAL MANAGEMENT, LP | $6,165,713 | 75,588 | 0.11% | 株式数 |
| PINNACLE ASSOCIATES LTD | $5,745,383 | 70,435 | 0.11% | 株式数 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $5,744,722 | 84,320 | 0.11% | 株式数 |
| VANGUARD ASSET MANAGEMENT, Ltd | $5,614,300 | 68,828 | 0.10% | 株式数 |
| Capricorn Fund Managers Ltd | $5,212,323 | 63,900 | 0.10% | 株式数 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5,000,241 | 61,300 | 0.09% | コールオプション |
| INTECH INVESTMENT MANAGEMENT LLC | $4,696,882 | 57,581 | 0.09% | 株式数 |
| ExodusPoint Capital Management, LP | $4,672,166 | 57,278 | 0.09% | 株式数 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $4,561,884 | 55,926 | 0.08% | 株式数 |
| BARCLAYS PLC | $4,169,858 | 51,120 | 0.08% | 株式数 |
| ORBIMED ADVISORS LLC | $4,005,087 | 49,100 | 0.07% | 株式数 |
| MetLife Investment Management, LLC | $3,932,653 | 48,212 | 0.07% | 株式数 |
| Point72 Europe (London) LLP | $3,829,919 | 62,407 | 0.07% | 株式数 |
| MILLENNIUM MANAGEMENT LLC | $3,792,516 | 46,494 | 0.07% | 株式数 |
| Phocas Financial Corp. | $3,766,087 | 46,170 | 0.07% | 株式数 |
| MARTINGALE ASSET MANAGEMENT L P | $3,627,826 | 44,475 | 0.07% | 株式数 |
| Quadrature Capital Ltd | $3,589,488 | 44,005 | 0.07% | 株式数 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3,531,981 | 43,300 | 0.07% | プットオプション |
| STATE OF WISCONSIN INVESTMENT BOARD | $3,436,299 | 42,127 | 0.06% | 株式数 |
| CREDIT AGRICOLE S A | $3,344,370 | 41,000 | 0.06% | 株式数 |
| Fisher Asset Management, LLC | $3,322,345 | 40,730 | 0.06% | 株式数 |
| HSBC HOLDINGS PLC | $3,200,425 | 38,732 | 0.06% | 株式数 |
| NEW YORK STATE COMMON RETIREMENT FUND | $3,134,490 | 38,427 | 0.06% | 株式数 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $3,114,179 | 38,178 | 0.06% | 株式数 |
| CenterBook Partners LP | $3,082,938 | 37,795 | 0.06% | 株式数 |
| Rafferty Asset Management, LLC | $3,069,805 | 37,634 | 0.06% | 株式数 |
| FIFTH THIRD BANCORP | $3,044,843 | 37,328 | 0.06% | 株式数 |
| BURNEY CO/ | $3,044,192 | 37,320 | 0.06% | 株式数 |
| Vanguard Global Advisers, LLC | $3,033,180 | 37,185 | 0.06% | 株式数 |
| Arrowpoint Investment Partners (Singapore) Pte. Ltd. | $3,007,731 | 36,873 | 0.06% | 株式数 |
| Louisiana State Employees Retirement System | $2,969,148 | 36,400 | 0.05% | 株式数 |
| JANE STREET GROUP, LLC | $2,854,950 | 35,000 | 0.05% | プットオプション |
| CASTLEARK MANAGEMENT LLC | $2,765,223 | 33,900 | 0.05% | 株式数 |
企業インサイダー 33 人のインサイダー · 13人の役員 · 14人の取締役
| インサイダー | 役職 | 最終アクティビティ | 保有株式数 | 12ヶ月購入 | 12ヶ月売却 | 12ヶ月純額 |
|---|---|---|---|---|---|---|
| Stuart Walter Peltz | Chief Executive Officer | 2022年2月1日 S | 38,728 | 0 | 0 | $0 |
| Pierre Gravier | CHIEF FINANCIAL OFFICER | 2026年7月14日 S | 83,986 | 0 | 1 | $-280,743 |
| Emily Luisa Hill | Chief Financial Officer | 2022年2月1日 S | 37,169 | 0 | 0 | $0 |
| Shane William Charles Kovacs | Chief Financial Officer | 2017年5月9日 M | 37,850 | 0 | 0 | $0 |
| Claudia De Oliveira Ribeiro Hirawat | President | 2015年1月15日 M | 39,247 | 0 | 0 | $0 |
| Marcio Souza | Chief Operating Officer | 2020年2月10日 M | 6,744 | 0 | 0 | $0 |
| Neil Gregory Almstead | CHIEF TECHNICAL OPS OFFICER | 2026年7月9日 M | 60,299 | 0 | 20 | $-9,184,852 |
| Mark Elliott Boulding | EXEC. VP AND CLO | 2026年7月6日 M | 105,272 | 0 | 12 | $-1,254,986 |
| Christine Marie Utter | SVP, CHIEF ACCOUNTING OFFICER | 2026年6月17日 M | 70,199 | 0 | 1 | $-1,487,474 |
| Eric Pauwels | CHIEF BUSINESS OFFICER | 2026年6月10日 S | 73,411 | 0 | 28 | $-7,477,160 |
| Mark Rothera | Chief Commercial Officer | 2017年5月24日 M | 33,739 | 0 | 0 | $0 |
| Tuyen Ong | Chief Medical Officer | 2017年1月3日 A | 6,000 | 0 | 0 | $0 |
| Robert J. Spiegel | Chief Medical Officer | 2016年1月4日 A | 3,239 | 0 | 0 | $0 |
| Hege Elisabeth Sollie-Zetlmayer | 取締役 | 2026年7月28日 A | 52,526 | 0 | 0 | $0 |
| Mary L. Smith | 取締役 | 2026年7月9日 M | 21,813 | 0 | 2 | $-1,425,060 |
| Stephanie Okey | 取締役 | 2022年1月7日 A | 4,163 | 0 | 0 | $0 |
| Emma Reeve | 取締役 | 2022年1月7日 A | 7,528 | 0 | 0 | $0 |
| Allan Steven Jacobson | 取締役 | 2022年1月7日 A | 8,348 | 0 | 0 | $0 |
| Dawn Svoronos | 取締役 | 2022年1月7日 A | 29,755 | 0 | 0 | $0 |
| Jerome B Zeldis | 取締役 | 2022年1月7日 A | 6,500 | 0 | 0 | $0 |
| Cameron Geoffrey Mcdonough | 取締役 | 2017年1月3日 A | — | 0 | 0 | $0 |
| Adam Koppel | 取締役 | 2017年1月3日 A | 2,333,333 | 0 | 0 | $0 |
| Ronald C Renaud JR | 取締役 | 2017年1月3日 A | — | 0 | 0 | $0 |
| Richard Aldrich | 取締役 | 2015年6月8日 M | 0 | 0 | 0 | $0 |
| Michael L Kranda | 取締役 | 2015年3月16日 S | 2,242 | 0 | 0 | $0 |
| Axel Bolte | 取締役 | 2013年6月25日 P | 20,000 | 0 | 0 | $0 |
| HBM Healthcare Investments (Cayman) Ltd. | 10%オーナー | 2013年12月17日 S | 2,441,504 | 0 | 0 | $0 |
| Matthew B. Klein | — | 2026年8月4日 S | 383,868 | 0 | 1 | $-705,722 |
| Michael Schmertzler | — | 2026年1月2日 A | 163,266 | 0 | 0 | $0 |
| Glenn Steele JR MD PHD | — | 2026年1月2日 A | 22,500 | 0 | 1 | $-916,200 |
| David P Southwell | — | 2026年1月2日 A | 20,850 | 0 | 0 | $0 |
| Complete Pharma Holdings II, LLC | — | 2017年4月28日 J | 0 | 0 | 0 | $0 |
| CREDIT SUISSE/ | — | 2013年6月25日 C | 2,256,882 | 0 | 0 | $0 |
SECフォーム3/4/5提出書類からのインサイダー；純額＝公開市場のP/Sのみ
アクティビストおよび5%超のオーナー 3保有
SECスケジュール13Dを提出した投資家 — 発行体の影響を与える意図（アクティビストの保有、取締役会キャンペーン、M&A）を持つ5%超の受益権所有。各行は、その提出者のポジションの最新の既知の状態を示します。
| 提出者 | 提出済み | 保有 | ステータス | 目的 | 提出書類 |
|---|---|---|---|---|---|
| Brookside Capital Partners Fund, L.P., Brookside Capital Trading Fund, L.P. ×5 提出書類 | 2015年1月30日 | — | 初回提出 | — | SEC |
| HBM Healthcare Investments (Cayman) Ltd. (“HBM”) ×2 提出書類 | 2014年11月12日 | — | 初回提出 | — | SEC |
| HBM Healthcare Investments (Cayman) Ltd. | 2013年7月5日 | — | 初回提出 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF保有状況 87のETFが保有
ウェイトは直接株式保有（N-PORT）のみを反映しています。レバレッジ型またはデリバティブベースのファンドは、表示されていない追加のスワップエクスポージャーを保有している可能性があります。
| ファンド | ウェイト | 単位 | 時点 | ソース |
|---|---|---|---|---|
| IBRN · iShares Trust | 3.81% | 4,145 SH | 2026年8月8日 | 日次 |
| PSCH · Invesco Exchange-Traded Fund Trust … | 3.08% | 71,992 SH | 2026年8月8日 | 日次 |
| PBE · Invesco Exchange-Traded Fund Trust | 2.59% | 128,216 SH | 2026年8月8日 | 日次 |
| XSMO · Invesco Exchange-Traded Fund Trust | 1.52% | 642,023 SH | 2026年8月8日 | 日次 |
| BBP · ETFis Series Trust I | 1.37% | 12,510 NS | 2026年4月30日 | N-PORT |
| SIXS · EXCHANGE TRADED CONCEPTS TRUST | 1.30% | 22,380 NS | 2026年5月31日 | N-PORT |
| RZG · Invesco Exchange-Traded Fund Trust | 1.25% | 23,662 SH | 2026年8月8日 | 日次 |
| GURU · Global X Funds | 1.03% | 9,268 NS | 2026年4月30日 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.93% | 73,928 NS | 2026年4月30日 | N-PORT |
| VAMO · Cambria ETF Trust | 0.83% | 10,625 NS | 2026年4月30日 | N-PORT |
| VIOG · VANGUARD ADMIRAL FUNDS | 0.74% | 98,733 SH | 2026年8月8日 | 日次 |
| VMAX · Lattice Strategies Trust | 0.72% | 5,120 NS | 2026年4月30日 | N-PORT |
| IJT · iShares Trust | 0.66% | 770,376 SH | 2026年8月8日 | 日次 |
| FNY · First Trust Exchange-Traded AlphaDE… | 0.51% | 40,257 NS | 2026年4月30日 | N-PORT |
| MMSC · First Trust Exchange-Traded Fund VI… | 0.49% | 3,490 NS | 2026年5月31日 | N-PORT |
| CLSE · Trust for Professional Managers | 0.49% | 40,488 NS | 2026年5月31日 | N-PORT |
| IBB · iShares Trust | 0.44% | 588,017 SH | 2026年8月8日 | 日次 |
| HQGO · Lattice Strategies Trust | 0.43% | 3,203 NS | 2026年4月30日 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.41% | 4,514 SH | 2026年8月8日 | 日次 |
| OASC · Unified Series Trust | 0.40% | 4,569 NS | 2026年5月31日 | N-PORT |
| BRNY · EA Series Trust | 0.40% | 34,057 NS | 2026年4月30日 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0.37% | 290,018 SH | 2026年8月8日 | 日次 |
| XJR · iShares Trust | 0.37% | 9,802 SH | 2026年8月8日 | 日次 |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.34% | 35,034 NS | 2026年5月31日 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.34% | 75,795 SH | 2026年8月8日 | 日次 |
| ESSC · Strategy Shares | 0.34% | 1,335 NS | 2026年4月30日 | N-PORT |
| IJR · iShares Trust | 0.32% | 5,058,562 SH | 2026年8月8日 | 日次 |
| IWO · iShares Trust | 0.31% | 641,280 SH | 2026年8月8日 | 日次 |
| BIB · ProShares Trust | 0.31% | 3,062 NS | 2026年5月31日 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0.31% | 11,451 NS | 2026年5月31日 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0.30% | 39,411 NS | 2026年5月31日 | N-PORT |
| SAA · ProShares Trust | 0.26% | 961 NS | 2026年5月31日 | N-PORT |
| ROUS · Lattice Strategies Trust | 0.25% | 22,443 NS | 2026年4月30日 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.24% | 27,276 NS | 2026年4月30日 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0.23% | 2,877 NS | 2026年4月30日 | N-PORT |
| AFSM · First Trust Exchange-Traded Fund VI… | 0.23% | 3,003 NS | 2026年5月31日 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.20% | 477,030 SH | 2026年8月8日 | 日次 |
| FNX · First Trust Exchange-Traded AlphaDE… | 0.20% | 39,967 NS | 2026年4月30日 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0.19% | 1,099,640 SH | 2026年8月8日 | 日次 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.18% | 72,691 SH | 2026年8月8日 | 日次 |
| IWM · iShares Trust | 0.18% | 2,102,256 SH | 2026年8月8日 | 日次 |
| LRGF · iShares Trust | 0.16% | 84,151 SH | 2026年8月8日 | 日次 |
| ISCG · iShares Trust | 0.16% | 22,792 SH | 2026年8月8日 | 日次 |
| RSSL · Global X Funds | 0.16% | 34,125 NS | 2026年4月30日 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.15% | 11,071 NS | 2026年4月30日 | N-PORT |
| ITWO · ProShares Trust | 0.15% | 3,710 NS | 2026年5月31日 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0.14% | 35,428 SH | 2026年8月8日 | 日次 |
| FSMD · FIDELITY COVINGTON TRUST | 0.14% | 49,932 NS | 2026年4月30日 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.14% | 5,350 SH | 2026年8月8日 | 日次 |
| SMDX · Tidal Trust III | 0.13% | 2,579 NS | 2026年4月30日 | N-PORT |